- $4.01bn
 - $4.12bn
 - $441.54m
 
- 83
 - 13
 - 96
 - 71
 
Annual balance sheet for TransMedics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st  | 2021 December 31st  | 2022 December 31st  | 2023 December 31st  | 2024 December 31st  | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — | 
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K | 
| Standards: | USG | USG | USG | USG | USG | 
| Status: | Final | Final | Final | Final | Final | 
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 126 | 92.5 | 201 | 395 | 337 | 
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 6.86 | 5.93 | 27.6 | 63.6 | 97.7 | 
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 147 | 119 | 252 | 511 | 497 | 
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 4.75 | 15.7 | 24.4 | 180 | 292 | 
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 152 | 135 | 277 | 706 | 804 | 
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 11.9 | 23.2 | 23.7 | 54.9 | 59.9 | 
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 48.1 | 67 | 89.8 | 569 | 575 | 
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 104 | 67.9 | 187 | 137 | 229 | 
| Total Liabilities & Shareholders' Equity | 152 | 135 | 277 | 706 | 804 | 
| Total Common Shares Outstanding |